Your browser doesn't support javascript.
loading
Corrigendum to CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/m-TOR pathway in vitro and in vivo: [Urol Oncol. 2018 Jun;36(6):312.e1-312.e8. / URO-D-17-00654R1].
Yan, Yutao; Du, Caiqi; Li, Guohao; Chen, Lin; Yan, Yubo; Chen, Gang; Hu, Weifeng; Chang, Lei.
Afiliação
  • Yan Y; Institute of Organ, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Organ Transplantation, Ministry of Health, China; Key Laboratory of Organ Transplantation, Ministry of Education, China.
  • Du C; Department of Pediatric, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li G; Department of Urology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Chen L; Department of Urology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yan Y; Shenzhen Cell Inspire Bio, Shenzhen, China.
  • Chen G; Institute of Organ, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Key Laboratory of Organ Transplantation, Ministry of Health, China; Key Laboratory of Organ Transplantation, Ministry of Education, China.
  • Hu W; Department of Urology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Chang L; Department of Urology, Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: changlei1025@163.com.
Urol Oncol ; 40(12): 542, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36216662

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China